1. Home
  2. News
  3. Henan Lingrui Pharmaceutial Co., Ltd.
  4. Announcement on Results of Shareholding Reduction by Director
More Henan Lingrui Pharmaceutial Co., Ltd. news
Henan Lingrui Pharmaceutial Co., Ltd.SSE: 600285

Announcement on Results of Shareholding Reduction by Director

Jan 15, 2026 · Issued by Henan Lingrui Pharmaceutial Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Jan 15, 2026 · 3 pages · Chinese

On 6ix: 6ix.com/news/announcement-on-results-of-shareholding-reduction-by-director

Henan Lingrui Pharmaceutial Co., Ltd. on 6ix

Earlier from Henan Lingrui Pharmaceutial

  • Announcement on "Corporate Value and Return Enhancement" Action PlanJan 1
  • Announcement on Resignation of Senior Management MemberDec 31, 2025
  • Announcement on Convening the Q3 2025 Performance BriefingNov 11, 2025
  • Announcement on Canceling the Board of Supervisors and Amending the Articles of Association and Some Corporate Governance SystemsOct 30, 2025
  • Announcement on Shareholding Reduction Plan for DirectorsSep 16, 2025

Later from Henan Lingrui Pharmaceutial

  • Announcement on the Pledge of Partial Shares by the Majority ShareholdersMar 25
  • Announcement on Renewing Engagement of Accounting FirmApr 28
  • Announcement on Obtaining Drug Registration CertificateApr 29
  • Announcement on the Release of Pledge of Partial Shares by Major ShareholdersApr 30
  • Announcement on Election of Employee Representative Directors for the 10th Board of DirectorsMay 21
All Henan Lingrui Pharmaceutial news releases↗

Follow Henan Lingrui Pharmaceutial into a list and get an email when it puts out news.

Follow Henan Lingrui Pharmaceutial
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer